BAM
CVS icon

Bellevue Asset Management’s CVS Health CVS Stock Holding History

Bellevue Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.7K Buy
287
+8
+3% +$714 0.01% 224
2026
Q1 		$20K Buy
279
+79
+40% +$6.09K 0.01% 238
2025
Q4 		$15.9K Buy
200
+50
+33% +$3.94K 0.01% 254
2025
Q3 		$11.3K Buy
150
+50
+50% +$3.43K 0.01% 273
2025
Q2 		$6.9K Hold
100
– – ﹤0.01% 309
2025
Q1 		$6.78K Hold
100
– – ﹤0.01% 302
2024
Q4 		$4.49K Sell
100
-112
-53% -$6.28K ﹤0.01% 357
2024
Q3 		$13.4K Buy
212
+1
+0.5% +$58 0.01% 258
2024
Q2 		$12.5K Sell
211
-595
-74% -$37.2K 0.01% 258
2024
Q1 		$64.3K Buy
806
+1
+0.1% +$76 0.04% 123
2023
Q4 		$63.6K Buy
805
+1
+0.1% +$71 0.06% 126
2023
Q3 		$56.1K Buy
804
+1
+0.1% +$71 0.04% 128
2023
Q2 		$55.5K Buy
803
+1
+0.1% +$71 0.03% 133
2023
Q1 		$59.6K Sell
802
-203
-20% -$17K 0.04% 130
2022
Q4 		$93.1K Hold
1,005
– – 0.07% 97
2022
Q3 		$98K Buy
1,005
+1
+0.1% +$99 0.08% 98
2022
Q2 		$93K Buy
1,004
+1
+0.1% +$98 0.07% 102
2022
Q1 		$102K Hold
1,003
– – 0.06% 106
2021
Q4 		$104K Buy
1,003
+1
+0.1% +$92 0.06% 115
2021
Q3 		$86K Hold
1,002
– – 0.05% 127
2021
Q2 		$84K Sell
1,002
-251
-20% -$20.6K 0.05% 136
2021
Q1 		$95K Hold
1,253
– – 0.06% 121
2020
Q4 		$92K Buy
1,253
+1
+0.1% +$65 0.06% 120
2020
Q3 		$73K Buy
1,252
+180
+17% +$11.2K 0.05% 127
2020
Q2 		$70K Sell
1,072
-28
-3% -$1.76K 0.07% 129
2020
Q1 		$70K Buy
1,100
+200
+22% +$13.4K 0.07% 128
2019
Q4 		$67K Buy
+900
New +$63.2K 0.05% 125

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bellevue Asset Management's CVS Position: Q2 2026 in Review

Bellevue Asset Management increased its CVS Health (CVS) stake by 2.9% in Q2 2026, buying an estimated $714 and bringing the position to 287 shares worth $29.7K. The position accounts for 0.01% of the portfolio, ranked #224.

Bellevue Asset Management first reported a position in CVS in Q4 2019 and has held it in 27 quarters since. The position peaked at $104K in Q4 2021. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Bellevue Asset Management held 287 shares of CVS Health worth $29.7K as of Q2 2026.
  • Bellevue Asset Management bought 8 CVS Health shares in Q2 2026, an estimated $714.
  • CVS Health made up 0.01% of Bellevue Asset Management's portfolio in Q2 2026, its #224 holding.
  • Bellevue Asset Management first reported a position in CVS Health in Q4 2019 and has held it in 27 quarters since.
  • Bellevue Asset Management's CVS Health position peaked at $104K in Q4 2021.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Bellevue Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.